Now speaking at Global Voices in Renal Oncology (VIRO) 2025, organized by OncoDaily: Dr. Rana McKay, Professor of Medicine and Urology at UC San Diego Health and Co-leader of the GU Oncology Program at Moores Cancer Center, leading a panel discussion on “Case-Based Presentation Risk Stratification and Perioperative Management for Localized Disease”.
Dr. McKay guided an interactive case discussion exploring preoperative risk assessment, surgical decision-making, and strategies for post-surgical management in localized RCC. The panel addressed how to evaluate operability, the role of novel biomarkers such as KIM-1 and advanced imaging tracers, and how perioperative clinical trials may influence treatment decisions.
Contributors emphasized that while surgery remains the foundation of care for most patients, integrating molecular tools and evolving systemic options can refine risk stratification and help personalize therapy, particularly for those at higher risk of recurrence.
Join us in this conversation.